Exagen Inc.
XGN
$3.02
-$0.15-4.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 66.58M | 63.60M | 58.86M | 56.72M | 55.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.58M | 63.60M | 58.86M | 56.72M | 55.64M |
| Cost of Revenue | 27.78M | 25.53M | 23.89M | 23.09M | 22.53M |
| Gross Profit | 38.80M | 38.07M | 34.98M | 33.64M | 33.11M |
| SG&A Expenses | 46.62M | 44.40M | 43.11M | 42.04M | 41.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 80.65M | 76.08M | 72.90M | 70.72M | 69.28M |
| Operating Income | -14.07M | -12.48M | -14.04M | -14.00M | -13.64M |
| Income Before Tax | -19.90M | -18.99M | -16.93M | -15.50M | -15.10M |
| Income Tax Expenses | 51.00K | 50.00K | 49.00K | 12.00K | 12.00K |
| Earnings from Continuing Operations | -19.95 | -19.04 | -16.98 | -15.51 | -15.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.95M | -19.04M | -16.98M | -15.51M | -15.12M |
| EBIT | -14.07M | -12.48M | -14.04M | -14.00M | -13.64M |
| EBITDA | -11.95M | -10.55M | -12.30M | -12.29M | -11.91M |
| EPS Basic | -0.92 | -0.93 | -0.89 | -0.84 | -0.83 |
| Normalized Basic EPS | -0.52 | -0.48 | -0.53 | -0.53 | -0.52 |
| EPS Diluted | -0.92 | -0.93 | -0.89 | -0.84 | -0.83 |
| Normalized Diluted EPS | -0.52 | -0.48 | -0.53 | -0.53 | -0.52 |
| Average Basic Shares Outstanding | 86.16M | 81.01M | 76.33M | 73.42M | 72.81M |
| Average Diluted Shares Outstanding | 86.16M | 81.01M | 76.33M | 73.42M | 72.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |